Power Law company profile

Cardioxyl Pharmaceuticals

Biotech & Life Sciences · Chapel Hill, United States · Founded 2005 Unicorn

Develops and commercializes therapies for the treatment of cardiovascular disease

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

4 investors on Cardioxyl Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

NEA

Aurora Funds

Series B+ 2 investors entered at this stage

OrbiMed

Osage University Partners

Global footprint

Where Cardioxyl Pharmaceuticals has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Patent intelligence

$35M patent portfolio · 16 active families

Estimated portfolio value

$35M

204× smaller than top peer Janssen Vaccines ($7.1B)

16 active patent families

Where Cardioxyl Pharmaceuticals innovates NitroxylMedicinal chemistryHeart failurePharmaceutical SubstancesReperfusion injury

Where Cardioxyl Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Cardioxyl Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Cardioxyl Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Cardioxyl Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cardioxyl Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles